Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554 * These authors have contributed equally to this work. |
Kamei, K., Yoshioka, M., Terada, S., Tokunaga, Y., & Chen, Y. (15 July 2019). Three-dimensional cultured Liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells. Biomedical Microdevices, 21 (3), 1-9. doi:10.1007/s10544-019-0423-8 |
Tokunaga, Y., Shirouzu, M., Sugahara, R., Yoshiura, Y., Kiryu, I., Ototake, M., Nagasawa, T., Somamoto, T., & Nakao, M. (08 August 2017). Comprehensive validation of T- and B-cell deficiency in rag1-null zebrafish: Implication for the robust innate defense mechanisms of teleosts. Scientific Reports, 7 (1), 7536. doi:10.1038/s41598-017-08000-2 |
Watanabe, A., Amano, N., Tokunaga, Y., Poolsap, U., & Yamanaka, S. (March 2014). Evaluation of safety of induced pluripotent stem cells by genome integrity. Inflammation and Regeneration, 34 (2), 87-93. doi:10.2492/inflammregen.34.087 |
Ohnuki, M., Tanabe, K., Sutou, K., Teramoto, I., Sawamura, Y., Narita, M., Nakamura, M., Tokunaga, Y., Nakamura, M., Watanabe, A., Yamanaka, S., & Takahashi, K. (2014). Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proceedings of the National Academy of Sciences of the United States of America, 111 (34), 12426-31. doi:10.1073/pnas.1413299111 |